Neither heterozygous nor homozygous carriage of these polymorphisms associated with metabolic syndrome biomarkers; however, individuals homozygous for the NOD1 variant had positive correlations with increased saturated fat intake and insulin resistance that were not observed in other genotypes [5]. This evidence concerns the gene NOD1 and metabolic syndrome.